0000896262-23-000054.txt : 20230613 0000896262-23-000054.hdr.sgml : 20230613 20230613105309 ACCESSION NUMBER: 0000896262-23-000054 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230608 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20230613 DATE AS OF CHANGE: 20230613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 231010544 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 8-K 1 amed-20230608.htm 8-K amed-20230608
AMEDISYS INC0000896262false00008962622023-06-082023-06-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 8, 2023

Commission File Number: 0-24260

Image_0.jpg
AMEDISYS, INC.
(Exact Name of Registrant as specified in its Charter) 
  
Delaware11-3131700
(State or other jurisdiction
(IRS Employer
of incorporation or organization)
Identification No.)
3854 American Way, Suite A, Baton Rouge, LA 70816
(Address of principal executive offices, including zip code)
(225) 292-2031 or (800) 467-2662
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share AMED The NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
    



SECTION 5 – CORPORATE GOVERNANCE AND MANAGEMENT

Item 5.07     Submission of Matters to a Vote of Security Holders.

Amedisys, Inc. (the “Company”) held its annual meeting of stockholders on Thursday, June 8, 2023 (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on four proposals. A brief description of and tabulation of votes for each proposal are set forth below.
Proposal 1. The Company’s stockholders elected the following nine directors for a term of one year. There were 1,039,290 broker non-votes with respect to the proposal.

Nominee
For
Withheld
Richard M. Ashworth
28,843,954
291,449
Vickie L. Capps
28,530,632
604,771
Molly J. Coye, MD
27,497,790
1,637,613
Julie D. Klapstein
27,400,427
1,734,976
Teresa L. Kline
28,350,393
785,010
Paul B. Kusserow
28,352,829
782,574
Bruce D. Perkins
28,767,548
367,855
Jeffrey A. Rideout, MD
28,534,512
600,891
Ivanetta Davis Samuels
28,585,947
549,456

Proposal 2. The Company’s stockholders ratified the selection of KPMG LLP as the Company’s independent registered public accountants for the fiscal year ending December 31, 2023. There were no broker non-votes with respect to the proposal.

For
Against
Abstain
29,134,996
1,030,677
9,020

Proposal 3. The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation paid to the Company’s named executive officers. There were 1,039,290 broker non-votes with respect to the proposal.

For
Against
Abstain
25,585,302
3,529,623
20,478


Proposal 4. The Company's stockholders expressed their preference to conduct future advisory votes on executive compensation every year. Consistent with the recommendation of the Board of Directors of the Company as set forth in the Company’s proxy statement for the Annual Meeting and the vote of the stockholders at the Annual Meeting, the Board of Directors has determined to include an advisory stockholder vote on executive compensation in the Company's proxy materials every year. This policy will remain in effect until the next stockholder vote on the frequency of stockholder votes on executive compensation. There were 1,039,290 broker non-votes with respect to the proposal.

One YearTwo YearsThree YearsAbstain
28,501,0336,372617,41610,582

    


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMEDISYS, INC.


By: /s/ Richard Ashworth    
Richard Ashworth
President and Chief Executive Officer

DATE: June 13, 2023



    
EX-101.SCH 2 amed-20230608.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 amed-20230608_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Address, Suite Entity Address, Address Line Two Entity Tax Identification Number Entity Tax Identification Number Entity Address, Street Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover page. Cover [Abstract] Title of each class Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Name of each exchange on which registered Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 4 amed-20230608_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 5 amed-20230608_g1.jpg begin 644 amed-20230608_g1.jpg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htm IDEA: XBRL DOCUMENT v3.23.1
Cover Document
Jun. 08, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 08, 2023
Entity File Number 0-24260
Entity Registrant Name AMEDISYS INC
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 11-3131700
Entity Address, Street 3854 American Way
Entity Address, Suite Suite A
Entity Address, City Baton Rouge
Entity Address, State LA
Entity Address, Postal Zip Code 70816
City Area Code 225
Local Phone Number 292-2031
Title of each class Common Stock, par value $0.001 per share
Trading Symbol AMED
Name of each exchange on which registered NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000896262
Amendment Flag false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 7 amed-20230608_htm.xml IDEA: XBRL DOCUMENT 0000896262 2023-06-08 2023-06-08 AMEDISYS INC 0000896262 false 8-K 2023-06-08 0-24260 DE 11-3131700 3854 American Way Suite A Baton Rouge LA 70816 225 292-2031 false false false false Common Stock, par value $0.001 per share AMED NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Document Sheet http://www.amedisys.com/role/CoverDocument Cover Document Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName - amed-20230608.htm 4 amed-20230608.htm amed-20230608.xsd amed-20230608_lab.xml amed-20230608_pre.xml amed-20230608_g1.jpg http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "amed-20230608.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "amed-20230608.htm" ] }, "labelLink": { "local": [ "amed-20230608_lab.xml" ] }, "presentationLink": { "local": [ "amed-20230608_pre.xml" ] }, "schema": { "local": [ "amed-20230608.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "amed", "nsuri": "http://www.amedisys.com/20230608", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "amed-20230608.htm", "contextRef": "i1197e59225ad476a960832c2c53a7d31_D20230608-20230608", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Document", "menuCat": "Cover", "order": "1", "role": "http://www.amedisys.com/role/CoverDocument", "shortName": "Cover Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "amed-20230608.htm", "contextRef": "i1197e59225ad476a960832c2c53a7d31_D20230608-20230608", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Street" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Suite" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of each class" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Name of each exchange on which registered" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.amedisys.com/role/CoverDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0000896262-23-000054-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000896262-23-000054-xbrl.zip M4$L#!!0 ( *16S59HSF0>W1D %'E 1 86UE9"TR,#(S,#8P."YH M=&WM/5EWVDRR[_,K^C+WSN><@[#VA22>0PSV1V*!C;$]\.+3DEH@K(61A%E^ M_:V6(#:;C>,%2)2'&&V]5%77VE7]Y=\CST7W)(R

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end